Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.143
Filtrar
Adicionar filtros

Ano de publicação
Intervalo de ano
2.
MMWR Morb Mortal Wkly Rep ; 69(49): 1868-1872, 2020 Dec 11.
Artigo em Inglês | MEDLINE | ID: covidwho-1024819

RESUMO

The Head Start program, including Head Start for children aged 3-5 years and Early Head Start for infants, toddlers, and pregnant women, promotes early learning and healthy development among children aged 0-5 years whose families meet the annually adjusted Federal Poverty Guidelines* throughout the United States.† These programs are funded by grants administered by the U.S. Department of Health and Human Services' Administration for Children and Families (ACF). In March 2020, Congress passed the Coronavirus Aid, Relief, and Economic Security (CARES) Act,§ which appropriated $750 million for Head Start, equating to approximately $875 in CARES Act funds per enrolled child. In response to the coronavirus disease 2019 (COVID-19) pandemic, most states required all schools (K-12) to close or transition to virtual learning. The Office of Head Start gave its local programs that remained open the flexibility to use CARES Act funds to implement CDC-recommended guidance (1) and other ancillary measures to provide in-person services in the early phases of community transmission of SARS-CoV-2, the virus that causes COVID-19, in April and May 2020, when many similar programs remained closed. Guidance included information on masks, other personal protective equipment, physical setup, supplies necessary for maintaining healthy environments and operations, and the need for additional staff members to ensure small class sizes. Head Start programs successfully implemented CDC-recommended mitigation strategies and supported other practices that helped to prevent SARS-CoV-2 transmission among children and staff members. CDC conducted a mixed-methods analysis to document these approaches and inform implementation of mitigation strategies in other child care settings. Implementing and monitoring adherence to recommended mitigation strategies reduces risk for COVID-19 transmission in child care settings. These approaches could be applied to other early care and education settings that remain open for in-person learning and potentially reduce SARS-CoV-2 transmission.


Assuntos
/prevenção & controle , Creches/organização & administração , Escolas Maternais/organização & administração , /epidemiologia , Centers for Disease Control and Prevention, U.S. , Pré-Escolar , Guias como Assunto , Humanos , Lactente , Recém-Nascido , Estados Unidos/epidemiologia
3.
J Perinatol ; 40(Suppl 1): 36-46, 2020 09.
Artigo em Inglês | MEDLINE | ID: covidwho-1023856

RESUMO

OBJECTIVES: To determine the relationship between the emergence of COVID-19 and neonatal intensive care unit (NICU) family presence as well as how NICU design affects these changes. STUDY DESIGN: A cross-sectional survey from April 21 to 30, 2020. We queried sites regarding NICU demographics, NICU restrictions on parental presence, and changes in ancillary staff availability. RESULTS: Globally, 277 facilities responded to the survey. NICU policies preserving 24/7 parental presence decreased (83-53%, p < 0.001) and of preserving full parental participation in rounds fell (71-32%, p < 0.001). Single-family room design NICUs best preserved 24/7 parental presence after the emergence of COVID-19 (single-family room 65%, hybrid-design 57%, open bay design 45%, p = 0.018). In all, 120 (43%) NICUs reported reductions in therapy services, lactation medicine, and/or social work support. CONCLUSIONS: Hospital restrictions have significantly limited parental presence for NICU admitted infants, although single-family room design may attenuate this effect.


Assuntos
Betacoronavirus , Infecções por Coronavirus , Administração Hospitalar , Unidades de Terapia Intensiva Neonatal/organização & administração , Pandemias , Pais , Pneumonia Viral , Visitas a Pacientes/estatística & dados numéricos , Estudos Transversais , Arquitetura Hospitalar , Humanos , Recém-Nascido , Política Organizacional , Quartos de Pacientes , Estados Unidos
4.
J Perinatol ; 40(5): 820-826, 2020 05.
Artigo em Inglês | MEDLINE | ID: covidwho-1023850

RESUMO

BACKGROUND: Little is known about the perinatal aspects of COVID-19. OBJECTIVE: To summarize available evidence and provide perinatologists/neonatologists with tools for managing their patients. METHODS: Analysis of available literature on COVID-19 using Medline and Google scholar. RESULTS: From scant data: vertical transmission from maternal infection during the third trimester probably does not occur or likely it occurs very rarely. Consequences of COVID-19 infection among women during early pregnancy remain unknown. We cannot conclude if pregnancy is a risk factor for more severe disease in women with COVID-19. Little is known about disease severity in neonates, and from very few samples, the presence of SARS-CoV-2 has not been documented in human milk. Links to websites of organizations with updated COVID-19 information are provided. Infographics summarize an approach to the pregnant woman or neonate with suspected or confirmed COVID-19. CONCLUSIONS: As the pandemic continues, more data will be available that could lead to changes in current knowledge and recommendations.


Assuntos
Infecções por Coronavirus , Transmissão Vertical de Doença Infecciosa/prevenção & controle , Pandemias , Pneumonia Viral , Complicações Infecciosas na Gravidez/virologia , Betacoronavirus , Infecções por Coronavirus/epidemiologia , Infecções por Coronavirus/prevenção & controle , Feminino , Humanos , Recém-Nascido , Masculino , Pandemias/prevenção & controle , Pneumonia Viral/epidemiologia , Pneumonia Viral/prevenção & controle , Gravidez , Fatores de Risco
6.
Arch Med Res ; 51(7): 603-607, 2020 10.
Artigo em Inglês | MEDLINE | ID: covidwho-1023465

RESUMO

Coronavirus disease 2019 (COVID-19), a new type and rapidly spread viral pneumonia, is now producing an outbreak of pandemic proportions. The clinical features and laboratory results of different age groups are different due to the general susceptibility of the disease. The laboratory findings of COVID-19 in pregnant women are also conflicting. Para-clinical investigations including laboratory tests and radiologic findings play an important role in early diagnosis and treatment monitoring of COVID-19. The majority of previous reports on the COVID-19 laboratory results were based on data from the general population and limited information is available based on age difference and pregnancy status. This review aimed to describe the COVID-19 laboratory findings in neonates, children, adults, elderly and pregnant women altogether for the first time. The most attracting and reliable markers of COVID-19 in patients were: normal C-reactive protein (CRP) and very different and conflicting laboratory results regardless of clinical symptoms in neonates, normal or temporary elevated CRP, conflicting WBC count results and procalcitonin elevation in children, lymphopenia and elevated lactate dehydrogenase (LDH) in adult patients, lymphopenia and elevated CRP and LDH in the elderly people, leukocytosis and elevated neutrophil ratio in pregnant women.


Assuntos
Complicações Infecciosas na Gravidez , Adolescente , Adulto , Idoso , Biomarcadores/sangue , /diagnóstico , /normas , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Gravidez , Complicações Infecciosas na Gravidez/sangue , Complicações Infecciosas na Gravidez/diagnóstico , Complicações Infecciosas na Gravidez/epidemiologia , Adulto Jovem
8.
Journal of the College of Physicians and Surgeons Pakistan ; 30(10):S136, 2021.
Artigo | WHO COVID | ID: covidwho-1024874
9.
Scientific Chronicles ; 25(2):238-256, 2020.
Artigo | WHO COVID | ID: covidwho-1023112

RESUMO

"Coronavirus of Wuhan" or "new Coronavirus" or SARS - CoV - 2 (Severe Acute Respiratory Syndrome Coronavirus - 2) causes an infection known as COVID - 19 Infection is transmitted mainly by inhalation or contact of infected droplets after coughing and sneezing by symptomatic or asymptomatic patients The main characteristic clinical feature of COVID - 19 is fever accompanied by cough and/or shortness of breath To confirm the diagnosis, molecular testing is required for sputum smears or secretions, preferably from the lower respiratory tract, and for computed tomography of the lungs There is no specific treatment Adherence to the basic principles of prenatal pregnancy management, during labour and postnatal pregnancy the should be of paramount importance and necessity, in order to ensure better health for both the mother and the fetus and newborn This article examines COVID - 19 infections in pregnancy, mainly in the diagnosis and basic principles of women's management during pregnancy, childbirth and lactation, the proper application of which is estimated to ensure that the transmission of the virus is avoided both in the mother and in the newborn

10.
Não convencional | Literatura cinzenta | ID: grc-743726

RESUMO

This is an information note designed to provide information on issues relating to breastfeeding when COVID-19 is suspected, probable, or confirmed It includes information on the following: protective effect of breastfeeding;standard infant feeding guidelines;support for breastfeeding mothers;feeding of newborn infants;mothers who are symptomatic or severely ill;no promotion of breastmilk substitutes

11.
Rev. peru. ginecol. obstet. (En línea) ; 66(2): 00008, abr-jun 2020. tab, graf
Artigo em Espanhol | LILACS (Américas) | ID: covidwho-1022717

RESUMO

Resumen Se presenta un caso de atención de parto eutócico sin complicaciones en una paciente COVID-19 positivo. La mujer de 33 años, tercigesta de 39 semanas, controlada en una clínica privada, acudió en trabajo de parto presentando tos no asociada a otra sintomatología. Fue diagnosticada con COVID-19 por prueba rápida IgM (+) IgG (-). Se realizó el aislamiento y se proveyó de equipo de protección personal según protocolo de la clínica. El trabajo de parto fue manejado según condiciones obstétricas, con analgesia epidural en fase activa, y teniendo como resultado un recién nacido sin complicaciones. No se realizó contacto piel a piel ni clampaje tardío. Ambos fueron dados de alta sin complicaciones previo período de aislamiento del recién nacido con estudios negativos para COVID-19. Se les realizó seguimiento telefónico en casa. En el caso presentado, se cumplió con el protocolo recomendado para la atención del parto durante la pandemia de COVID-19.


Abstract We present the case of a eutocic, uncomplicated delivery in a patient positive for COVID-19. The patient, a 33-year-old woman, 39 weeks pregnant, who had received prenatal care in a private clinic, presented in labor, coughing, without any other symptoms. She was diagnosed with COVID-19 by rapid test, IgM (+) and IgG (-). We isolated the patient and provided personal protective equipment following our clinic's protocol. Delivery was managed according to obstetric conditions, applying epidural anesthesia in the active phase; the baby was born without complications. Nor skin-to-skin contact nor delayed umbilical cord clamping were performed. Mother and child were discharged without complications after the newborn completed the required isolation period, testing negative for COVID-19. Telephone follow-up was performed. The healthcare team followed the recommended protocol to manage delivery during the COVID-19 pandemic.

12.
Health Promot Chronic Dis Prev Can ; 40(11-12): 336-341, 2020 12 09.
Artigo em Inglês, Francês | MEDLINE | ID: covidwho-1022346

RESUMO

INTRODUCTION: Research has shown that during the 2003 SARS pandemic, emergency department (ED) visits among the pediatric population decreased. We set out to investigate if this was also true for injury-related ED visits during the COVID-19 pandemic. METHODS: Using data from the Canadian Hospitals Injury Reporting and Prevention Program (CHIRPP), we looked at 28 years of injury-related ED visits at the Montreal Children's Hospital, a provincially designated Pediatric Trauma Centre. We compared data from a two-month period during the COVID-19 lockdown (16 March to 15 May) to the same period in previous years (1993-2019) to determine whether the 2020 decrease in ED visit numbers was unprecedented (i.e. a similar decrease had never occurred) for different age groups, nature of injuries, mechanisms and severity. RESULTS: The 2020 decrease was unprecedented across all age groups between 1993 and 2019. When compared with the 2015 to 2019 average, the decrease was smallest in children aged 2 to 5 years (a 35% decrease), and greatest in the group aged 12 to 17 years (83%). Motor vehicle collisions and sports-related injuries practically vanished during the COVID-19 lockdown. Surprisingly, more children aged 6 to 17 years presented with less urgent injuries during the COVID-19 lockdown than in previous years. CONCLUSION: As was the case with SARS in 2003, COVID-19 acted as a deterrent for pediatric ED visits. The lockdown in particular had a profound impact on injury-related visits. The de-confinement period will be monitored to determine the impact in both the short and the long term.


Assuntos
/epidemiologia , Serviço Hospitalar de Emergência/estatística & dados numéricos , Ferimentos e Lesões/epidemiologia , Acidentes de Trânsito/estatística & dados numéricos , Adolescente , Traumatismos em Atletas/epidemiologia , Criança , Pré-Escolar , Feminino , Hospitais Pediátricos/estatística & dados numéricos , Humanos , Lactente , Recém-Nascido , Masculino , Fatores de Proteção , Quebeque/epidemiologia , Ferimentos e Lesões/etiologia
13.
CMAJ ; 193(1): E1-E9, 2021 01 04.
Artigo em Inglês | MEDLINE | ID: covidwho-1021694

RESUMO

BACKGROUND: Research involving children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has primarily focused on those presenting to emergency departments. We aimed to determine the symptoms most commonly associated with a positive result for a SARS-CoV-2 swab among community-based children. METHODS: We conducted an observational study among children tested and followed for SARS-CoV-2 infection using nasal, nasopharyngeal, throat or other (e.g., nasopharyngeal aspirate or tracheal secretions, or unknown) swabs between Apr. 13 and Sept. 30, 2020, in Alberta. We calculated positive likelihood ratios (LRs) for self-reported symptoms and a positive SARS-CoV-2 swab result in the entire cohort and in 3 sensitivity analyses: all children with at least 1 symptom, all children tested because of contact tracing whether they were symptomatic or not and all children 5 years of age or older. RESULTS: We analyzed results for 2463 children who underwent testing for SARS-CoV-2 infection; 1987 children had a positive result and 476 had a negative result. Of children with a positive test result for SARS-CoV-2, 714 (35.9%) reported being asymptomatic. Although cough (24.5%) and rhinorrhea (19.3%) were 2 of the most common symptoms among children with SARS-CoV-2 infection, they were also common among those with negative test results and were not predictive of a positive test (positive LR 0.96, 95% confidence interval [CI] 0.81-1.14, and 0.87, 95% CI 0.72-1.06, respectively). Anosmia/ageusia (positive LR 7.33, 95% CI 3.03-17.76), nausea/vomiting (positive LR 5.51, 95% CI 1.74-17.43), headache (positive LR 2.49, 95% CI 1.74- 3.57) and fever (positive LR 1.68, 95% CI 1.34-2.11) were the symptoms most predictive of a positive result for a SARS-CoV-2 swab. The positive LR for the combination of anosmia/ageusia, nausea/vomiting and headache was 65.92 (95% CI 49.48-91.92). INTERPRETATION: About two-thirds of the children who tested positive for SARS-CoV-2 infection reported symptoms. The symptoms most strongly associated with a positive SARS-CoV-2 swab result were anosmia/ageusia, nausea/vomiting, headache and fever.


Assuntos
/diagnóstico , Técnicas de Laboratório Clínico/métodos , Pandemias , Manejo de Espécimes/métodos , Adolescente , Alberta/epidemiologia , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino
14.
Pediatr Infect Dis J ; 40(1): e7-e11, 2021 01.
Artigo em Inglês | MEDLINE | ID: covidwho-1020315

RESUMO

OBJECTIVE: The COVID pandemic has affected Colombia with a high number of cases and deceases; however, no studies have been published regarding pediatric population. An epidemiologic analysis of the nationwide COVID register, therefore, is necessary to outline and describe the impact in such population. METHODS: A retrospective analysis was made of the characteristics of a cohort of 5062 patients <18 years of age, until June 16, 2020, reported at the National Institute of Health-INS (https://www.ins.gov.co/News./Pages/Coronavirus.aspx), through the national public access database, with all subjects confirmed with COVID-19 or severe acute respiratory syndrome-CoV-2. RESULTS: Reviewed on June 16, 2020, a total of 54,971 confirmed cases were reported nationwide for COVID-19, of which 5062 (9.2%) are cases in patients under 18 years of age. There was a statistically significant difference between groups; age was statistically significantly higher in the asymptomatic, compared with: deceased, severe and moderate cases; moreover, age was statistically significantly higher in the mild, compared with: deceased, severe and moderate. Statistically significant difference determined with one-way ANOVA was found between groups (F = 16.08, P < 0.001). Post hoc analysis reveals significant differences between groups, the age of patients at home (9.39 years) and those recovered (9.3 years) being significantly higher than those in intensive care unit (4.9 years), in hospital (6.1 years), or than the deceased (2.9 years). CONCLUSION: The results of this study show that, at the nationwide level, patients in more severe states (deceased, severe and moderate), are significantly younger than those in the milder state (asymptomatic and mild).


Assuntos
/epidemiologia , /patologia , Adolescente , Fatores Etários , Infecções Assintomáticas , Criança , Pré-Escolar , Colômbia/epidemiologia , Feminino , Hospitalização/estatística & dados numéricos , Humanos , Lactente , Recém-Nascido , Masculino , Estudos Retrospectivos , Índice de Gravidade de Doença
15.
Metas enferm ; 23(5):22-32, 2020.
Artigo | WHO COVID | ID: covidwho-1016883

RESUMO

OBJETIVO: recopilar y contrastar la información científica disponible respecto al SARS-CoV-2 durante el proceso gestacional y sus efectos en la paciente obstétrica durante el parto, puerperio y en el recién nacido MÉTODO: se realizó una revisión bibliográfica de la evidencia disponible en tres bases de datos internacionales: PubMed, Science Direct y Cochrane Se utilizaron términos estandarizados, lenguaje libre, sinónimos y truncamientos, combinándolos con operadores booleanos en función de la capacidad de cada base de datos Asimismo se han consultado las páginas web de organismos oficiales y sociedades científicas que abordaban el tema de embarazo y la COVID-19 RESULTADOS: se seleccionaron un total de 14 artículos y nueve guías de práctica clínica e informes técnicos procedentes de distintas organizaciones científicas nacionales e internacionales La bibliografía es escasa y con poca evidencia científica dada la novedad de la pandemia por este coronavirus, pero se encontraron documentos científicos que abordaban el embarazo y feto, parto, puerperio y recién nacido Se cree que el virus SARS-CoV-2 tiene reacciones menos adversas en la mujer embarazada y su recién nacido que otros virus de la misma familia Cada mujer gestante infectada y su neonato deben ser identificados y valorados precozmente, de manera individual y multidisciplinar, para prevenir resultados adversos y complicaciones No existe evidencia de la transmisión vertical del virus SARS-CoV-2 Hay discrepancias acerca del manejo del recién nacido de la mujer gestante infectada por COVID-19 CONCLUSIÓN: existen muchas lagunas de conocimiento en relación al manejo de la mujer gestante, parto, puerperio y recién nacido, ya que hay poca evidencia disponible OBJECTIVE: to collect and confirm the scientific information available regarding SARS-CoV-2 during the gestational process and its effects on the obstetric patient during delivery and puerperium, and on the newborn METHOD: a bibliographic review of the evidence available was conducted in three international databases: PubMed, Science Direct and Cochrane Standardized terms were used, as well as free language, synonyms and truncation, combining them with Boolean operators based on the capacity of each database Likewise, the webpages of official organizations and scientific societies addressing the matter of pregnancy and COVID-19 were also consulted RESULTS: in total, 14 articles and 9 clinical practice guidelines were selected, as well as technical reports from different national and international organizations There is limited bibliography, and with low scientific evidence, given the novelty of the pandemic caused by this coronavirus, but scientific documents were retrieved which addressed pregnancy and fetus, delivery, puerperium and newborns It is believed that the SARS-CoV-2 virus has less adverse reactions in the pregnant woman and her newborn than other viruses from the same class Each pregnant woman infected and her newborn should be subject to early identification and evaluation, in an individual and multidisciplinary way, in order to prevent adverse results and complications There is no evidence of the vertical transmission of the SARS-CoV-2 virus There are discrepancies regarding the management of newborns of pregnant women infected by COVID-19 CONCLUSION: there are many knowledge gaps regarding the management of pregnant women, delivery, puerperium and newborns, because there is limited evidence available

16.
Revista Española de Salud Pública ; 94:0-0, 2020.
Artigo | WHO COVID | ID: covidwho-1016731

RESUMO

OBJETIVO: El nuevo coronavirus es una enfermedad infecciosa causada por el virus SARS-Cov-2, considerada por la Organización Mundial de la Salud (OMS) una emergencia de salud pública de interés internacional (ESPII), la cual podría tener consecuencias negativas durante la lactancia materna El objetivo de este trabajo fue conocer el plan de actuación sobre la lactancia materna ante una mujer recién parida enferma de SARS-CoV-2 y su recién nacido MÉTODOS: Se realizó una búsqueda de la literatura a través de las bases de datos Medline, Web of Science, Scopus, BVS y Cuiden Se evaluó la calidad metodológica de los artículos mediante la herramienta "Grading of Recommendations Assessment, Development and Evaluation"(GRADE) No se registró en PROSPERO RESULTADOS: En total se encontraron 14 documentos, de los cuales 9 estudios empíricos estaban realizados mayormente en China, Italia, EEUU y Australia, estando basados en 114 madres infectadas de coronavirus SARS-CoV-2 y sus respectivos recién nacidos Los estudios analizados afirmaron que lo mejor para el recién nacido es ser alimentado con la leche materna, ya que se analizaron muestras de leche de madres infectadas por coronavirus detectándose la presencia de anticuerpos del virus en las mismas, siendo un factor protector contra la infección del virus CONCLUSIONES: La lactancia materna en recién paridas con SARS-CoV-2 es muy recomendable para el recién nacido, si el estado de salud de la madre y del neonato lo permiten, favoreciéndose el amamantamiento de forma directa y teniendo siempre las medidas adecuadas de higiene respiratoria En el caso de que el estado de salud de la madre no permita el amamantamiento directo se debería alimentar con leche materna extraída previamente de su madre y sin pasteurizar, o procedente de un banco de leche BACKGROUND: The new coronavirus disease is an infectious disease caused by the SARS-Cov-2 virus, considered by the World Health Organization (WHO) an international public health emergency that may have negative consequences during breastfeeding The objective of this work is to investigate the action plan on breastfeeding in postpartum women with SARS-CoV-2 and her newborn METHODS: A literature search has been conducted through the Medline, Web of Science, Scopus, BVS, and Cuiden databases The methodological quality of the articles has been assessed using the "Grading of Recommendations Assessment, Development and Evaluation"(GRADE) This study has not been registered in PROSPERO RESULTS: A total of 14 documents have been found, of which 9 are observational empirical studies Most of the studies were conducted in China, Italy, the USA, and Australia A total of 114 mothers infected with coronavirus with their respective newborns have been assessed The analyzed investigations state that it is best for the newborn to be breastfed;given that mother's milk samples were analyzed, detecting the presence of antibodies of the coronavirus in them, being a protective factor against infection CONCLUSIONS: Breastfeeding in postpartum women with SARS-CoV-2 is highly recommended for the newborn, if the health of the mother and newborn allow it When direct breastfeeding is favoured, the appropriate respiratory hygiene measures always have to be considered Whether the mother's health does not permit direct breastfeeding, her breast milk should be previously extracted and kept unpasteurized To secure the newborn feeding, milk banks are also an appropriate option

17.
Revista Española de Salud Pública ; 94:0-0, 2020.
Artigo | WHO COVID | ID: covidwho-1016694

RESUMO

FUNDAMENTOS: La enfermedad por coronavirus 2019 (COVID-19) es una nueva patología, declarada emergencia de salud pública por la Organización Mundial de la Salud, que puede tener consecuencias negativas en las embarazadas y sus recién nacidos El objetivo fue explorar el conocimiento disponible sobre las consecuencias de desarrollar COVID-19 en las embarazadas y en los recién nacidos durante el embarazo MÉTODOS: Se realizó una Scoping Review, en la que se usó la búsqueda de artículos en los directorios DeCS ("embarazo", "coronavirus", "salud") y MeSH ("pregnan*", "pregnant women", "coronavirus"), uniendo los términos con el operador booleano AND Se buscó en las bases de datos Web of Science, Scopus, BVS, Scielo y CUIDEN Además, se aplicó la metodología PRISMA RESULTADOS: Se identificaron 10 estudios en los que se evalúo la salud materna y neonatal tras infección materna por COVID-19 Las embarazadas parecían no presentar síntomas graves Los neonatos se veían afectados en mayor medida Se informó de un fallecimiento de un recién nacido prematuro cuya madre tuvo neumonía por COVID-19 No pareció haber transmisión vertical de madre a hijo, aunque esta información no era concluyente CONCLUSIONES: El COVID-19 parece ser más benigno con las embarazadas que con sus recién nacidos BACKGROUND: Coronavirus disease 2019 (COVID-19) is a new pathology, declared a public health emergency by the World Health Organization, which can have negative consequences for pregnant women and their newborns The aim of this study was to explore the available knowledge on the consequences of developing COVI-19 in pregnant women and their neonates METHODS: Scoping Review, in which the search for articles was conducted using DeCS ("pregnancy", "coronavirus", "health") and MeSH ("pregnan*", "pregnant women", "coronavirus"), linking the terms with the Boolean AND operator Databases used were Web of Science, Scopus, BVS, Scielo and CUIDEN In addition, the PRISMA methodology was applied RESULTS: Ten studies were identified that assessed maternal and neonatal health after maternal COVID-19 infection Pregnant women seem to had no serious symptoms Neonates appeared to be affected to a greater extent A death was reported in a premature newborn whose mother had COVID-19 pneumonia There did not appear to be vertical transmission from mother to child Nevertheless, this information was not conclusive CONCLUSIONS: COVID-19 appears to be more benign with pregnant women than with their neonates

18.
Preprint | SciFinder | ID: ppcovidwho-5255

RESUMO

A review Since Dec 2019, Wuhan City, Hubei Province has discovered many cases of new coronavirus-infected pneumonia patients With the spread of the epidemic, such cases have also been found in other regions of China and abroad As an acute respiratory infectious disease, the disease was included in Category B infectious diseases as stipulated in the Law of the People's Republic of China on the Prevention and Control of Infectious Diseases on Jan 20, 2020, and is managed as Category A infectious diseases WHO in 2020 On Jan 30, it was announced that the new coronavirus epidemic was listed as a public health emergency of international concern With the progress of the epidemic and the development of etiol testing, reports of children 's infections are gradually increasing There are many cases of children 's reports, and there are cases of infant and newborn infections With the deepening of disease knowledge and the accumulation of experience in diagnosis and treatment, the National Health and Health Commission has now formulated the "New Coronavirus Infection Pneumonia Diagnosis and Treatment Program (Trial Sixth Edition)" [1] The Pediatric Branch of the Chinese Medical Association is concluding On the basis of confirmed cases of children, the "Diagnosis and Prevention Recommendations for Children's 2019 New Coronavirus Infection (Trial First Version)" [2], recently issued by the International Virus Classification Committee(International Committee on Taxonomy of Viruses, ICTV) officially identified the name of the new coronavirus as severe acute Respiratory syndrome coronavirus type 2 (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) According to the epidemic situation in Chongqing, combined with the characteristics of children's diseases, on the basis of the revision of the "Diagnosis and Treatment Plan for New Coronavirus Infection in Children's Hospital of Chongqing Medical University (First Edition)", the "New Coronavirus for Children in Children's Hospital of Chongqing Medical University" was formulated Infection diagnosis and treatment plan (trial second edition) "

19.
Epidemiol Prev ; 44(5-6 Suppl 2): 369-373, 2020.
Artigo em Inglês | MEDLINE | ID: covidwho-1016518

RESUMO

During a pandemic, pregnancy and the postnatal period are complicated by multiple factors. On the one hand, worries about one's own health and the health of loved ones, in particular of the newborn child, can increase the risk of some mental disorders, such as depression and anxiety in the pregnant woman. On the other hand, as happened for the COVID-19 epidemic in Italy, given the need for physical distancing, the maintenance of the social and family network, so important for new parents in the perinatal period, is lacking. In addition, health services are forced to reorganize their offerings to ensure maximum safety for their operators and patients. This work proposes a model of screening and treatment aimed at identifying women at risk and providing them with effective and safe treatment.

20.
Archives of Pathology & Laboratory Medicine ; 144(10):1217-1222, 2020.
Artigo | WHO COVID | ID: covidwho-1016380

RESUMO

Context - The pandemic of a novel coronavirus, termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has created an unprecedented global health burden Objective - To investigate the effect of the SARS-CoV-2 infection on maternal, fetal, and neonatal morbidity and other poor obstetrical outcomes Design - All suspected cases of pregnant women with coronavirus disease 2019 (COVID-19) admitted into one center in Wuhan from January 20 to March 19, 2020, were included Detailed clinical data of those pregnancies with COVID-19 were retrospectively collected and analyzed Results - Twenty-seven pregnant women (4 early pregnancies included) with laboratory or clinically confirmed SARS-CoV-2 infection and 24 neonates born to the 23 women in late pregnancy were analyzed On admission, 46 2% (13 of 27) of the patients had symptoms, including fever (11 of 27), cough (9 of 27), and vomiting (1 of 27) Decreased total lymphocytes count was observed in 81 5% (22 of 27) of patients Twenty-six patients showed typical viral pneumonia by chest computed tomography scan, whereas 1 patient confirmed with COVID-19 infection showed no abnormality on chest computed tomography One mother developed severe pneumonia 3 days after her delivery No maternal or perinatal death occurred Moreover, 1 early preterm newborn born to a mother with the complication of premature rupture of fetal membranes, highly suspected to have SARS-CoV-2 infection, was SARS-CoV-2 negative after repeated real-time reverse transcriptase polymerase chain reaction testing Statistical differences were observed between the groups of women in early and late pregnancy with COVID-19 in the occurrence of lymphopenia and thrombocytopenia Conclusions - No major complications were reported among the studied cohort, though 1 serious case and 1 perinatal infection were observed Much effort should be made to reduce the pathogenic effect of COVID-19 infection in pregnancies

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA